Gliclazide - Isotope Labelled Standards
References
FAQ's
References
- Beregi, Laszlo; Hugon, Pierre; Duhault, Jacques, New Sulphonylurea Derivatives and Process for preparing them, GB1153982A, Jun 4, 1969, Science Union et Cie., Societe Francaise de Recherche Medicale (https://www.lens.org/lens/search/patent/list?q=GB1153982)
- Kimura, Masako; Kobayashi, Kunio; Hata, Mitsuo; Matsuoka, Akira; Kaneko, Shigeo; Kitamura, Hisami; Kimura, Yukio, Reversed-phase high-performance liquid chromatographic determination of gliclazide in human plasma, Chemical & Pharmaceutical Bulletin, Volume: 28, Issue: 1, Pages: 344-6, 1980 DOI: (10.1248/cpb.28.344)
Frequently Asked Questions
2.Under which conditions do Gliclazide degradation products form?
Gliclazide degradation products form under acid hydrolysis and photolytic conditions.
3.Why is it crucial to remove Gliclazide impurities from the drug?
It is essential to remove Gliclazide impurities from the drug for effective quality control, safety, and efficacy.
4.Which analytical method identifies the Gliclazide impurities?
A thin-layer chromatographic and densitometric method identifies the Gliclazide impurities.
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.